James Madison University

JMU Scholarly Commons
Masters Theses, 2010-2019

The Graduate School

5-2-2019

Does acute preprandial exercise modify postprandial
inflammation after a high fat meal in young and older adults?
William Wisseman

Follow this and additional works at: https://commons.lib.jmu.edu/master201019
Part of the Diseases Commons, and the Kinesiology Commons

Recommended Citation
Wisseman, William, "Does acute preprandial exercise modify postprandial inflammation after a high fat
meal in young and older adults?" (2019). Masters Theses, 2010-2019. 631.
https://commons.lib.jmu.edu/master201019/631

This Thesis is brought to you for free and open access by the The Graduate School at JMU Scholarly Commons. It
has been accepted for inclusion in Masters Theses, 2010-2019 by an authorized administrator of JMU Scholarly
Commons. For more information, please contact dc_admin@jmu.edu.

Does acute preprandial exercise modify postprandial inflammation
after a high fat meal in young and older adults?
William Wisseman

A thesis submitted to the Graduate Faculty of
JAMES MADISON UNIVERSITY
In
Partial Fulfillments of the Requirements
For the degree of
Master of Science

Department of Kinesiology

August 2019
FACULTY COMMITTEE:
Committee Chair: Dr. Stephanie P. Kurti
Committee Members/ Readers:
Dr. Elizabeth S. Edwards
Dr. Nicholas D. Luden
Dr. Christopher J. Womack

Acknowledgments
I would like to thank Dr. Stephanie Kurti for serving as my thesis advisor, thesis
committee chair, and mentor.
Thank you to Dr. Liz Edwards for serving as co-chair on my thesis committee. Your
diligence and eye for detail was invaluable during the initial phases of the project and
throughout the data collection process. Without your organization and meticulousness this
project might not have happened.
I would also like to thank Dr. Nicolas Luden and Dr. Christopher Womack for
valuable feedback, support, and insights they brought to this project.
This project would also not have been possible without the hours of assistance from
the undergraduate Kinesiology students.

ii

Table of Contents
Acknowledgements………………………………………………………………………..ii
Table of Contents…...…………………………………………………………………….iii
List of Tables………………………………………………………….………………….iv
List of Figures……………………………………………………………………………..v
Abstract…………………………………………………………………………………...vi
I.

Introduction………………………………………………………………..…1

II.

Methods………………………………………………………………………10

III.

Manuscript.…………………...…………………………………………..…..16

IV.

Appendices…………………………………………………………………...46

V.

References…………………………………..…………………………….….74

iii

List of Tables
Table 1. Protocols for incremental VO2peak cycle ergometer test based on subject
determined warm up wattage.
Table 2. Participant characteristics.
Table 3. High fat meal (HFM) composition and exercise session calculations for
YA and OA. Exercise duration was capped at two hours, three OA participant’s
calculated exercise duration exceeded the two hour cap.

iv

List of Figures
Figure 1. Energy expenditure formula used to determine the exercise duration that
is equivalent to 75% of the caloric content from the HFM.
Figure 2. Protocol for the HFM sessions. Time increments are in minutes. P: plasma
collected for inflammation markers, G: glucose collected; L: lipids collected.
Satiety collected via SLIM scale.
Figure 3. Metabolic response to HFM and EX+HFM in YA and OA. (a)
triglycerides, (b) LDL, (c) blood glucose. Dashed lines and empty markers
indicated EX+HFM, solid lines and filled markers indicate HFM, triangles indicate
YA and circles indicate OA. * Indicates within group significance compared to
baseline. ⱡ Indicates between group significance for age. Error bars indicate 95%
CI. Significance set at p<0.05.
Figure 4. Cytokine response to HFM and EX+HFM in YA and OA at baseline, 3
hours, and 6 hours postprandially. (a) IL-6, (b) IL-8, (c) IL-10, (d) IL-1β, (e) TNFα.
Dashed lines and empty markers indicated EX+HFM, solid lines and filled markers
indicate HFM, triangles indicate YA and circles indicate OA. * Indicates within
group significance compared to baseline. ⱡ Indicates between group significance for
age. Error bars indicate 95% CI. Significance set at p<0.05.

v

Abstract
A single high-fat meal (HFM) can increase systemic inflammation (postprandial
inflammation; PPI) and may be attenuated by recent exercise. However, the effect of
preprandial exercise on PPI in older adults (OA) is not clear. Purpose: To determine if
preprandial exercise attenuates PPI in YA and OA. Methods: 12 YA (23.3±3.9 years n= 5
M/7 F) and 12 OA (67.7±6 years, n= 8 M/4 F) completed two HFM challenges in a
randomized order. During HFM alone, participants abstained from exercise 48 hours prior
to the HFM session (except for the exercise session) and adhered to a 12 hour overnight
fast. Baseline measurements were taken immediately before participants consumed the
HFM (12 kcals/kg BW: 57% fat, 39% CHO, 4% PRO), and then again three and six hours
postprandially. In exercise + HFM (EX+HFM) participants performed exercise at a heart
rate that corresponded to 65% VO2Peak until caloric expenditure matched 75% of the caloric
content of the HFM, then adhered to a 12 hour overnight fast before consuming the HFM.
Results: All markers of inflammation were lower at three hours postprandially regardless
of condition or age (p<0.05). Furthermore, IL-10 (93% of baseline) and TNFα (88% of
baseline) remained below baseline concentrations at six hours (p<0.05) while IL-6, IL8,
and IL-1β increased back to baseline levels (p>0.05). TNFα was greater in OA at baseline
compared to YA (p<0.05), but not at three or six hours postprandially (p>0.05). There was
no difference in inflammation between HFM and EX+HFM at any time point (p>0.05).
Conclusion: Contrary to our hypotheses, a HFM did not elicit PPI in YA or OA.
Additionally, exercise did not impact inflammation at any timepoint. Future work should
be performed on the PPI response and the effect of preprandial exercise on individuals
already afflicted with inflammation related diseases.
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Chapter I
Western Diet
The typical western diet consists of nutrient poor and calorically dense foods,
including red meats, simple refined carbohydrates, and saturated or trans fats. Research
into the potential health risks of the western diet has increased over the past decades in
reaction to the increased prevalence of lifestyle disease in the American population1.
Specifically, the prevalence of obesity, cardiovascular disease, hypertension, and type II
diabetes has increased in tandem with the proliferation of chronic high-fat and high calorie,
westernized diets2. While the negative health effects from chronic westernized diets have
been well characterized and may extend beyond obesity3, the adverse health effects of
regular high-fat meals may arise prior to the onset of obesity. It is likely that there are
adverse metabolic and immune responses result from a single high-fat, westernized meal3–
5

. Research has shown the influence of a single HFM on complex physiological functions6

(i.e. inflammation, immune system, metabolism), which provides insights into the
mechanistic role a chronic westernized diet has on the risk of metabolic and cardiovascular
disease development. A key mechanism initiating the development of chronic diseases may
be the prolonged activation of innate and acquired immune pathways.
Innate Immune System and Inflammation
The innate immune system is the first response to tissue damage or the presence of
invading antigens7. Activation of the innate immune system is characterized by the
mobilization of neutrophils, macrophages8, and natural killer (NK) cells9 . These cells
engulf the pathogens to be destroyed within the cell or secrete other proinflammatory
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cytokines to mediate additional inflammatory effects8. Interleukin-6 (IL-6) is a proinflammatory cytokines that recruits T cells and B cells from the acquired immune system
to aid in managing invading pathogens10.
Inflammation is a complex, multi-regulated, physiological response to tissue
damage or invading pathogens11. Classical inflammation is associated with swelling and
tenderness from a laceration or damaged muscles that is easily visible and causes
discomfort. However, classical inflammation is not an urgent problem for most people and
is resolved by the coordination of innate immune responses and tissue healing within days
of injury. Inflammation can also be caused by invading pathogens, which provoke an acute
inflammatory response at a subclinical level. Regular exposure to such pathogens results
in the prolonged presence of pro-inflammatory cytokines involved in the subclinical
response and promotion of a state of persistent low-grade, systemic inflammation. It
appears that this type of chronic, low-grade systemic inflammation plays a detrimental role
in human health. The presence of low-grade inflammation has been associated with
increased risk of cardiovascular disease12,13, vascular diseases14, atherosclerosis15, type II
diabetes16, Alzheimer’s disease17, and various cancers18,19.
Damage to the vascular tissue by penetration of pathogens triggers an innate
immune response and a pro-inflammatory cascade that begins with monocytes arriving at
the site of endothelial cell activation. Monocytes enter vascular tissue around activated
endothelial cells and differentiate into macrophages20 which absorb circulating pathogens
in an effort to prevent further damage. Working macrophages subsequently secrete two
types of acute phase inflammatory proteins, interleukin-6 (IL-6) and tumor necrosis factor-
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α21 (TNF-α). IL-6 and TNF-α are two upstream mediators that further contribute to the proinflammatory cascade22,23.
IL-6 is a multifunctional, polypeptide protein hormone24. Depending on the
interaction of IL-6 with either IL-6 receptor (IL-6R) or soluble IL-6 receptor (sIL-6R) 25,26,
IL-6 can mediate either a pro or ant-inflammatory response. During an innate immune
response, IL-6 is synthesized and secreted from active pro-inflammatory M1 macrophages.
As a pro-inflammatory cytokine, IL-6 is the key regulator of secondary acute phase
inflammatory protein synthesis in the liver, such as c-reactive protein27 (CRP), a marker of
chronic inflammatory.
IL-6 also contributes to creating an environment that is more prone to chronic
inflammation26. Prolonged secretion of IL-6 stimulates more IL-6 synthesis and secretion,
as well as B cell differentiation, T cell activation, and immunoglobulin secretion 26. This
leads to an increase in monocyte recruitment which then stimulates secretion of IL-8 and
monocyte chemoattractant protein 1 (MCP-1)28. MCP-1 stimulates the recruitment of
additional monocytes, which differentiate into inflammatory macrophages within the
vascular tissue29. The shift to more tissue resident macrophages creates an environment
that can more easily promote inflammation via IL-6 and TNF-α synthesis and secretion26,30.
TNF-α is regulated by nuclear factor-kappa-B (NF-kB) and mediates inflammation
by modifying endothelial leukocyte function. These cells exhibit altered combinations of
leukocyte adhesion molecules E-selectin, vascular cell adhesion molecule-1(VCAM-1),
and intercellular adhesion molecule-126 (ICAM-1). ICAM-1 and VCAM-1 are essential in
promoting macrophage infiltration into vascular and adipose tissue. ICAM-1 and VCAM-

4

1 also increase the rate at which inflammatory cytokines adhere to the endothelium, which
contributes to the development and progression of atherosclerosis.
Inflammation is a complex process involving collaborating systems, cytokines, and
molecules. Chronic inflammation is achieved through continued activation of acute
inflammation responses. These consequences of regular acute inflammation creates an
environment of chronic, low-grade inflammation and highlights the importance of
minimizing exposure to inflammatory stimuli. A frequent HFMs may be a stimuli for such
consequences, and lead to chronic inflammation process through repeated increases in
postprandial lipemia and acute inflammation.
Postprandial Lipemia and Inflammation
High and/or moderate fat meals consisting of 0.4-1.5 g of fat/kg bw can elicit a
significant increase in postprandial lipemia31 (PPL), typically measured through blood
triglyceride (TG) concentrations. Even a single HFM increases circulating triglycerides
and very low density lipoprotein (VLDL) concentration. Elevated levels of TG cause a
decrease in high density lipoproteins (HDL) and an increase in low density lipoproteins32
(LDL). LDLs are a smaller, denser derivative of VLDLs, formed as a result of the
breakdown of circulating triglycerides. LDLs can penetrate endothelial cells of the vascular
wall and initiate the inflammatory cascade previously mentioned33. Vascular tissue
penetration and endothelial cell activation has an immediate detrimental effect on
endothelial function34. The buildup of plaque on vascular walls enables greater monocyte
penetration, ultimately contributing to an environment that promotes inflammation.
Frequent consumption of 2-3 HFMs a day by many individuals means that they spend much
of the day in a state of postprandial lipemia and inflammation.
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Chronic, low-grade systemic inflammation has been reported to increase due to a
Westernized lifestyle. The scale of the postprandial inflammatory response after a single
HFM is dependent on the percent of saturated and trans fat within the meal as well as its
caloric density. Typical western meals contain approximately 20-40 grams of saturated fat.
Absolute saturated and trans fat content of 30-50 grams in a single meal causes significant
increases in circulating triglycerides35 (known as postprandial lipemia (PPL)) and possibly
postprandial inflammation (PPI) as a result of PPL. HFMs with relative saturated and trans
fat content in a meal of at least 60% also cause PPL and PPI.
Variations in Postprandial Inflammatory Responses
A wide range of macronutrient ratios have been used in PPI research. Increases in
IL-6 have been observed with fat percentages as low as 30% of the meal36, while meals
with up to 85% of the macronutrients from fat and have seen similar responses in
postprandial IL-6 concentrations37. Absolute versus relative total calories consumed is also
a factor in the PPI. There is substantial variation in absolute calorie content between meals
in the literature, ranging from 60038 kilocalories39,40 (kcals) to over 1470 kcals41.
Kračmerová and colleagues used a HFM containing over 1470 kcals with 46% fat, resulting
in significant increases in IL-6 and increased mRNA expression of TNF-α, MCP-1, and
other inflammatory markers such as IL-1β, and IL-8 in young healthy men. In contrast,
Drew and colleagues implemented a HFM containing 600 kcals with 50% fat and reported
increases in IL-6 and TNF-α that were 7% greater than those of Kračmerová and
colleagues. Relative caloric content is also commonly used in HFM challenges, because it
is more applicable to real-world eating habits. Results for HFMs relative caloric content
are consistent with those of the absolute caloric content42,43. Even though HFMs consisting
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of large absolute caloric content elicit large pro-inflammatory changes in IL-6 and possibly
TNF-α, more realistic meals with relative caloric content still elicit significant proinflammatory responses, though findings have been mixed.
It is understood that PPI may be dependent on the type of fat, the percentage of fat
in the meal, and the relative versus absolute calories consumed. However, recent studies
have also suggested that chronic physical activity level and participation in acute exercise
may be an important consideration in reducing chronic low-grade systemic inflammation
and acute PPI44.
The Effect of Exercise on Postprandial Inflammation
Exercise is a natural anti-oxidant45 and anti-inflammatory46, and therefore may
induce a systemic attenuation of PPI. The potential attenuation of PPI from exercise could
occur through several mechanisms. Exercise can act indirectly on PPI through mitigation
of the lipemic pathway of inflammation, through reduction of PPL via circulating LDL
through 47 and/or increased plasma VLDL clearance48, or by up-regulation of lipoprotein
lipase levels (LPL) at the skeletal muscle48, and increased lipid hydrolysis. LDL will
decrease as a result of these attenuations in VLDL, which will reduce scale of endothelial
activation and inflammation response. Alternatively, exercise can elicit a direct antiinflammatory state through increased anti-inflammatory cytokine secretion7.
Post exercise reductions in plasma VLDL levels results in decreased LDL
concentration and potential for endothelial activation. Moderate intensity exercise (60%
VO2MAX) performed the afternoon before a morning HFM has been shown to reduce
postprandial VLDL clearance by 40%, but not hepatic secretion48. Additionally, there
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appears to be a nonlinear dose response to exercise’s effect on VLDL dynamics. The effect
of an acute one hour moderate intensity cycling (60% VO2MAX) bout had a lesser effect on
VLDL levels compared to a 90 minute exercise session49, and changes in VLDL levels
nearly plateau as exercise exceeded two hours50,51. Exercise induced caloric deficit may
provide be the mediator for eliciting decreases in VLDL levels. Additionally, a threshold
caloric deficit of 500 kcals may exist, as there is minimal or absent reductions in VLDL
concentrations when energy expenditure is less than 500 kcals52. However, inconsistencies
in changes in VLDL at this low caloric expenditure might suggest the need for a relative
caloric expenditure threshold, additional research needs to be conducted to confirm this
idea. The introduction of regular exercise in previously sedentary, healthy individuals as
well as type II diabetics decreases hepatic VLDL secretion47. This suggests a protective
benefit of chronic exercise. Exercise of similar duration and intensity needed to alter
hepatic VLDL secretion also increases LPL activity 8-22 hours after exercise53. Greater
mass and activity of LPL at the muscle and endothelial membrane upregulates lipoprotein
hydrolysis and reduces circulating lipoproteins52.
Regular physical activity appears to reduce fasting pro-inflammatory IL-6 levels in
healthy middle aged men for at least 24 hours after an individual’s last exercise bout.
However, postprandial IL-6 levels are no different between regularly active and inactive
men54 when exercise is abstained for 24 hours. This indicates that there might be a narrow
time frame for the direct anti-inflammatory effects of exercise. Working skeletal muscles
secrete anti-inflammatory IL-6 in concentrations up to 100 times greater than fasting levels
55,56

. Prolonged muscle contraction57 and the depletion of muscle glycogen stores58 appear

to be the main stimulus for increases in anti-inflammatory IL-6. IL-6 freely enters the
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bloodstream after secretion from skeletal muscle, eliciting a systemic effect predominantly
mediated by inhibiting the release of pro-inflammatory cytokines TNF-α and IL-1 in
addition to upregulating the production of anti-inflammatory interleukin-10 (IL-10).
Circulating IL-10 mediates many of the systemic anti-inflammatory benefits of
exercise59. IL-10 directly downregulates pro-inflammatory cytokines and inhibits
production of ICAM1 which both reduce pro-inflammatory capacity60. Additionally, IL10 down regulates macrophage concentrations and also reduce macrophage penetration
into adipose and muscular cells in mice trials61. Thus, exercise can have a large and
systemic anti-inflammatory response that directly counteracts multiple pro-inflammatory
pathways.
Exercise Prescriptions for Attenuating PPI
Due to the link between PPL and PPI, the ability of exercise to attenuate the increase
in postprandial circulating TG indicates its effectiveness at also attenuating PPI as well as
increased anti-inflammatory IL-6 and IL-10 production. Research into type, duration, and
intensity of exercise show that certain modalities and prescriptions are more effective than
others31. In a review by Freese and colleagues, low to moderate intensity exercise (d = 0.58; P < 0.0001) and high intensity interval exercise (>90% VO2Max) (d = -1.49; P <
0.0001) both significantly reduced PPL31 with high intensity interval exercise having the
largest impact. In contrast, resistance training did not significantly reduce PPL (d = -0.13;
P < 0.01)31. Yet, the effect that exercise duration and intensity have on PPL and PPI is
based on the caloric deficit they produce6.
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Additionally, the magnitude of the exercise induced caloric deficit varies widely in
the literature. Both absolute and relative energy expenditures are used to prescribe
preprandial and postprandial exercise. However, Katsanos and Moffatt suggest attenuation
of PPL is most commonly observed with preprandial exercise that reaches an energy
expenditure threshold of at least 500 kcals62. Several studies have utilized acute exercise
bouts where energy expenditures were over 1000 kcals. While these types of exercise bouts
elicit the greatest reductions in PPL, the intensity and duration of exercise to reach 1000
kcals is not feasible for most people and may not be true to life. To improve PPL and PPI
outcomes, but keep exercise realistic for most individuals, recent studies employ exercise
where caloric expenditure is in the range of 600-900 kcals, which may still attenuate PPL
and PPI.
Older Adults and Inflammation?
Systemic, low-grade inflammation, termed inflammaging, increases through the
aging process12,63. In addition, the immune system gradually deteriorates with age, known
as immunosenescence. Immunosenescence worsens the immune system’s response time
and effectiveness when pathogens are present, increasing susceptibility to disease and
illness12. A life time of poor lifestyle choices, including sedentary behavior and poor
dietary choices, results in more frequent exposure to various pathogens64. Prolonged
pathogen exposure may elicit subclinical inflammatory responses which mediate
inflammaging43 and cause greater damage to tissues and cells. In a 10 year longitudinal
study of 249 male and female older subjects age 67.5 + 2.4 years old, Bartlett and
colleagues reported significant increases in IL-6, TNF-α, and CRP63. Additionally, there
was a significant decrease in IL-10, indicating not only increased inflammation via greater
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concentrations of pro-inflammatory cytokines, but also through a reduction in antiinflammatory mediators.
Similar to low-grade, systemic inflammation that is not associated with age,
inflammaging is also strongly associated with diseases commonly seen in older
populations64. However, despite the growing numbers of older Americans, little research
has been done to determine the impact of a HFM on those 60 and older65,66. Inflammation
may magnify the normal PPI response observed in young adults. Furthermore, substantial
decreases in skeletal muscle mass and resting IL-10 levels suggest a decreased ability to
upregulate anti-inflammatory cytokines. Thus, the effect that acute and chronic exercise
have on PPI in young adults may vary when compared to older adults.
Purpose and Hypotheses
The purpose of this study is to determine whether an acute bout of preprandial
exercise attenuates the PPI response after a HFM in young and older adults. We
hypothesize that (1) an acute bout of physical activity will attenuate the postprandial
inflammatory response in young and older adults, (2) older adults will experience a greater
attenuation from acute exercise than young adults.

11

Chapter II
Methods
Subjects
Twenty-four subjects will be recruited for this study, of which there will be twelve
young adults between 18-35 years (n= 5 M / 7 F) and 12 older adults between 60-80 years
(n= 8 M/ 4 F). Subjects will be asked to complete a physical activity readiness
questionnaire (PAR-Q) to determine whether they are eligible to enroll in the study. They
also will complete the international physical activity questionnaire (I-PAQ) to determine
chronic physical activity level to estimate physical activity in MET-minutes/week.
Experimental Design
Each subject will complete a total of four laboratory visits. On the first visit, initial
baseline measures of height, weight, bodyfat percentage, and blood pressure will be taken
and VO2Peak will be determined. Subjects will then be randomly assigned an order to
perform two HFM challenges, either the HFM alone (HFM) or a HFM challenge with a
preprandial exercise session twelve hours prior to the meal (EX + HFM) that will be
conducted in the same lab. The experimental design can be seen displayed in Figure 1,
below.
Initial Measurements
The first laboratory visit will be used to collect baseline measurements. Height will
be taken with a stadiometer (Charder Model HM 200P, Charder Electronic Co Ltd.,
Taichung, Taiwan) and weight with a standard physician’s scale (Dymo Pelouze model
4040, Newell Brands, Hoboken, NJ) to calculate body mass index. Following height and
weight, a dual-energy x-ray absorptiometry (DEXA) (GE Lunar iDXA Fairfield, CT) scan

12

will be performed to calculate lean mass, fat mass, and percent body fat. Resting blood
pressure (BP) will be taken immediately after the DEXA is completed, so that the subject
will have been resting for at least five minutes. BP will be measured using an automatic
Sphygmomanometer (ProBP 3400 Welch Allyn, Skaneateles Falls, NY) as detailed in
American College of Sports Medicine (ACSM) Guidelines. The average of the two BP
measurements will be recorded. Waist circumference will be taken at the narrowest part of
the waist with a Gulick tape measurer (Creative Health Products, Ann Arbor, MI).
Maximal Exercise Testing
An incremental cycling test to exhaustion will be performed on a VIAsprint 150P
cycle ergometer (Vyaire Medical, Mettawa, IL) to determine VO2Peak. Expired air will be
analyzed by a Vmax Encore metabolic cart (Vyaire Medical, Lake Forest, IL), while heart
rate (HR) will be measured by a Polar Link heart rate strap and watch (Polar Lake Success,
NY). Once the headset, mouthpiece, and nose plug are fitted the subjects will complete a
five minute warm up at a self-selected cadence >50 revolutions per minute (rpm). During
the warm up, power output will be either increased or decreased every minute until subjects
identify a workload, they perceived as maintainable for approximately thirty minutes.
Based on the power output determined during the warm up, one of four potential
test protocols will be chosen (Table 1) in order to reach VO2Peak. Immediately after the
warm up, the incremental test will begin, and wattage will be set according to stage one of
the selected protocol. Resistance will then be increased every minute based on the protocol
being used (10 Watts or 25 Watts). Subjects will be verbally encouraged to continue
pedaling by the investigators throughout the exercise test. The test will be terminated when
subjects reach volitional exhaustion.
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Food Log and ASA24 Food Recall
Subjects will be given a food log and instructed to record, in detail, all foods and
beverages consumed the day before their HFM Challenge. For the second HFM Challenge,
subjects will be asked to duplicate their diet from the previous HFM Challenge as closely
as possible, and once again record in detail their diet for that day.
Preprandial Exercise Bout
During the EX + HFM trial, subjects will perform an acute exercise bout twelve
hours prior to their HFM challenge on the VIAsprint 150P cycle ergometer (Vyaire
Medical, Mettawa, IL), which was previously used for the VO2Max test. Wattage will be set
so that subjects’ HR stays within a HR range that corresponds to 60-70% of their VO2Peak
HR, for a duration long enough to achieve a total energy expenditure equivalent to 75% of
the calories of the HFM challenge (Equation 1). However, subjects will not be permitted
to exercise longer than 2-hours. After the exercise bout, subjects will be asked to adhere to
the same 12 hour overnight fast as they would for the non-exercise trial.
HFM Composition
Subjects will be asked to adhere to an overnight twelve hour fast before consuming
the HFM which will consist of a slice of Marie Callender's Chocolate Satin Pie (Conagra
Brands, Chicago, IL) portioned out to a caloric density of 12 kcals/kg bw. Macronutrient
composition of the HFM will be 57% fat (57% of which is saturated fat), 4% PRO, and
39% CHO.
HFM Challenge Day
After reporting to the lab, subjects will be seated in a reclining chair for the duration
of the HFM session. After resting for at least five minutes before two baseline BP
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measurements will be taken with at least 30 seconds of rest between each recording. An
indwelling safelet catheter will be inserted into a forearm vein via a 22-gauge needle
(Fisher Scientific, Waltham, MA) and kept patent with a 0.9% NaCl solution with a drip
rate of one/second. A fasting blood draw will be taken once the catheter is in place via a 5
mL syringe (BD) and emptied into a 6-mL EDTA-coated vacutainer tube. Subjects’ satiety
will then be recorded via the satiety labeled intensity magnitude (SLIM) Satiety Scale.
Following the baseline blood draw and SLIM rating, subjects will have 20 minutes to
consume the HFM.
Minimal movement will be allowed for the duration of the six hours after
consumption. The subject will not be allowed to stand up except for inside the restroom.
At every hour postprandially, subjects’ satiety will be recorded by the SLIM scale. Blood
draws will be taken to assess inflammatory markers at baseline, three hours, and six hours.
The experimental protocol is pictured in Figure 1.
Blood samples will be drawn every 30 minutes postprandially until the two hour
mark at which point draws will be performed every hour. Plasma (for inflammatory
markers), and blood glucose and lipids (Cardiochek Plus Analyzer, PTS Diagnostics,
Indianapolis, IN) will be tested prior to the HFM challenge. Plasma samples will be taken
at baseline, 3, and 6 hours. Blood glucose will be tested every 30 minutes up to 2 hours
postprandial, and then every hour. Blood lipids will be tested every hour from baseline
until 6 hours post-prandially.
Cytokine Analysis
After blood draws, samples will be transferred to six ml BD vacutainers and
immediately centrifuged for 12 minutes at 1800 x g and four degrees Celsius. After being
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separated blood plasma will be aliquoted into 0.5 ml microtainers and stored for later
investigation in a freezer at -80 C. All plasma samples will be assayed at Eve Technologies
(Calgary, Alberta, Canada). For this study, a Human High Sensitivity T-Cell Discovery
Array 14-plex (HDHSTC14) will be used to measure IL-6, IL-1β, IL-8, IL-10, and TNF-a.
Biomarkers will be analyzed in duplicate and the average measurement will be used for
analysis of coefficient of variance for each analyte.
Statistical Analysis
Statistical analysis will be done with IBM SPSS Statistics v26.0 (IBM Corporation,
Armonk, NY). To determine statistical significance with 80% power at an alpha level of
0.05 for determining differences in postprandial triglycerides based on age and activity
level, five participants will be needed. However, 12 participants will be recruited in each
group to detect changes in inflammatory responses. All data will be checked for normality
before analysis using the Shapiro-Wilk test. When data is not normally distributed, it will
be log-10 transformed and checked again for normality. A mixed factorial analysis of
variance (ANOVA) will be done with the within-subjects’ factor of time (baseline, three,
and six hours for cytokines) and condition (HFM or EX+HFM) and the between subjects’
factor of age (YA and OA) and if significant main effects of group or time are detected,
first data will assessed to determine significance as a linear or quadratic function. Next,
post hoc multiple comparisons will be conducted to test for group- or time-specific
differences. In this instance, Bonferroni adjustment for multiple comparisons will be
implemented to avoid type I error. Pearson’s r comparisons will be also be performed to
assess associations between PPL and PPI. For all analyses, significance will be set to
p<0.05.
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Abstract
A single high-fat meal (HFM) can increase systemic inflammation (postprandial
inflammation; PPI) and may be attenuated by recent exercise. However, the effect of
preprandial exercise on PPI in older adults (OA) is not clear. Purpose: To determine if
preprandial exercise attenuates PPI in YA and OA. Methods: 12 YA (23.3±3.9 years n= 5
M/7 F) and 12 OA (67.7±6 years, n= 8 M/4 F) completed two HFM challenges in a
randomized order. During HFM alone, participants abstained from exercise 48 hours prior
to the HFM session (except for the exercise session) and adhered to a 12 hour overnight
fast. Baseline measurements were taken immediately before participants consumed the
HFM (12 kcals/kg BW: 57% fat, 39% CHO, 4% PRO), and then again three and six hours
postprandially. In exercise + HFM (EX+HFM) participants performed exercise at a heart
rate that corresponded to 65% VO2Peak until caloric expenditure matched 75% of the caloric
content of the HFM, then adhered to a 12 hour overnight fast before consuming the HFM.
Results: All markers of inflammation were lower at three hours postprandially regardless
of condition or age(p<0.05). Furthermore, IL-10 (93% of baseline) and TNFα (88% of
baseline) remained below baseline concentrations at six hours (p<0.05) while IL-6, IL8,
and IL-1β increased back to baseline levels (p>0.05). TNFα was greater in OA at baseline
compared to YA (p<0.05), but not at three or six hours postprandially (p>0.05). There was
no difference in inflammation between HFM and EX+HFM at any time point (p>0.05).
Conclusion: Contrary to our hypotheses, a HFM did not elicit PPI in YA or OA.
Additionally, exercise did not impact inflammation at any timepoint. Future work should
be performed on the PPI response and the effect of preprandial exercise on individuals
already afflicted with inflammation related diseases.
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Introduction
The typical western diet consists of nutrient-poor and calorically-dense foods,
much of which include meals high in saturated and trans fats (high-fat meals; HFMs). In
addition, individuals may consume 2-3 HFMs a day, which means that they spend the
majority of the day in the postprandial state of a HFM. The negative health effects of
chronic high-fat diets may include obesity, type II diabetes, cardiovascular disease (CVD)
and other chronic diseases. A key mechanism initiating the development of chronic
diseases may be the prolonged activation of the innate immune system brought on by
postprandial lipemia (PPL), mainly the elevated levels of low density lipoproteins (LDLs)
in circulation after a HFM. Circulating LDLs cause damage to vascular tissue when they
penetrate the endothelial cells1. An inflammation response is launched to remove the LDLs.
Repeated exposure to PPL and the subsequent postprandial inflammation (PPI) creates a
chronic low-grade inflammatory environment2. Specifically, persistent low-grade
inflammation has been associated with increased risk of cardiovascular disease (CVD)3,4,
atherosclerosis5,

type II diabetes6, Alzheimer’s disease7, and certain cancers8,9.

Interestingly, even a single HFM can specific markers of inflammation which include creactive protein (CRP), interleukin-6 (IL-6), interleukin-1B (IL-1ß), and tumor necrosis
factor-a (TNF-α). Considering these inflammatory markers have been associated with
increased risk of the previously mentioned chronic diseases in a fasted state, modifying the
acute increase in these inflammatory markers may lead to a lower overall risk of chronic
disease development.
While a HFM transiently increases inflammation, aging also independently
increases the risk of chronic diseases, in part due to the decreases in immune function
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(termed immunosenescence)3,52, which occurs naturally with age (i.e. inflammaging).
There is also an age-related increase in systemic markers of inflammation, including CRP,
IL-8 and IL-610,11. In addition, there may be a decrease in anti-inflammatory IL-10 with
aging11 which may be due to decreased muscle mass and ability to secrete antiinflammatory cytokines10. Inflammaging, a westernized diet, and reduced antiinflammatory capacity may work synergistically to amplify PPI, leading to greater risk of
inflammation related disease for older adults (OA).
Fortunately, acute exercise has been utilized as a means to modify the acute
inflammatory response, likely by altering blood lipid dynamics12, 13 and/or by enabling the
secretion of anti-inflammatory cytokines through prolonged muscle contraction14. A single
bout of exercise within 24 of a HFM appears to have the greatest attenuation of PPL in
young adults (YA)15, however the impact of pre-prandial exercise on PPL remains to be
elucidated in OA. Therefore, the purpose of this study is to determine whether an acute
bout of preprandial exercise attenuates the PPI response after a HFM based on age. We
hypothesize that (1) an acute bout of physical activity will attenuate the postprandial
inflammatory response in YA and OA and (2) OA will experience a greater attenuation
from acute exercise than YA.
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Methods
Subjects
12 young adults (YA) between 20-33 yrs (23.3±3.9 yrs, n= 5 M/7 F) and 12 older
adults (OA) between 62-77 yrs (67.7±6 yrs, n= 8 M/4 F) participated in this investigation.
Subjects signed an informed consent, completed a physical activity readiness questionnaire
(PAR-Q), and the International Physical Activity Questionnaire (I-PAQ) to determine
chronic physical activity level in MET-minutes/week. Subject characteristics are displayed
in table 2. All procedures were approved by the James Madison University Institutional
Review Board in accordance with the Declaration of Helsinki.
Experimental Design
Each subject completed a total of four laboratory visits. On the first visit, initial
baseline measures of height, weight, body fat percentage, and blood pressure were taken.
The subjects then performed an incremental test to volitional exhaustion to determine peak
oxygen consumption (VO2Peak) and exercise intensity for the acute exercise condition.
Subjects were then randomly assigned an order to perform two HFM challenges, either the
HFM alone or exercise + HFM challenge with the preprandial exercise session occurring
twelve hours prior to the meal (EX + HFM). Subjects began each experimental trial in the
morning (starting time; 7:00-11:00 am) after a 12 hour overnight fast with identical starting
times within subjects. The experimental design is displayed in Figure 1.
Initial Measurements
The first laboratory visit was used to collect baseline measurements. Height was
taken with a stadiometer (Charder Model HM 200P, Charder Electronic Co Ltd., Taichung,
Taiwan) and weight with a standard physician’s scale (Dymo Pelouze model 4040, Newell
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Brands, Hoboken, NJ) to calculate body mass index. Following height and weight, a dualenergy x-ray absorptiometry (DEXA) (GE Lunar iDXA Fairfield, CT) scan was performed
to calculate lean mass, fat mass, and percent body fat. Resting blood pressure (BP) was
taken immediately after the DEXA was completed, so that the subject had been resting for
at least five minutes. BP was measured using an automatic Sphygmomanometer (ProBP
3400 Welch Allyn, Skaneateles Falls, NY) as detailed in the American College of Sports
Medicine (ACSM) Guidelines. The average of the two BP measurements were recorded.
Waist circumference was taken at the narrowest part of the waist with a Gulick tape
measurer (Creative Health Products, Ann Arbor, MI).
Incremental Exercise Test
An incremental cycling test to exhaustion was performed on a VIAsprint 150P
cycle ergometer (Vyaire Medical, Mettawa, IL) to determine VO2Peak. Breath samples were
analyzed by a Vmax Encore metabolic cart (Vyaire Medical, Lake Forest, IL), while heart
rate (HR) was measured by a Polar Link heart rate strap and watch (Polar Lake Success,
NY). Once the headset, mouthpiece, and nose plug were fitted, the subjects completed a
five-minute warm up at a self-selected cadence ≥50 revolutions per minute (rpm). During
the warm up, power output was either increased or decreased every minute until subjects
identified a workload that they perceived as sustainable for approximately thirty minutes.
Based on the power output determined during the warm up, one of four potential
test protocols was chosen (Table 1) in order to reach VO2Peak. Immediately after the warm
up, the incremental test began, and wattage was set according to stage one of the selected
protocol. Resistance was increased every minute based on the protocol being used (10
Watts or 25 Watts). Subjects were verbally encouraged to continue pedaling by the
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investigators throughout the exercise test. The test was terminated when subjects reached
volitional exhaustion.
Food Log and ASA24 Food Recall
Subjects were given a food log and instructed to record, in detail, all foods and
beverages consumed the day before their HFM challenge. For the second HFM challenge,
subjects were asked to duplicate their diet from the previous HFM challenge as closely as
possible, and once again record in detail their diet for that day.
Preprandial Exercise Bout
During the EX + HFM trial, subjects performed an acute exercise bout twelve hours
prior to their HFM challenge on the VIAsprint 150P cycle ergometer (Vyaire Medical,
Mettawa, IL), which was previously used for the VO2peak test. Wattage was set so that the
subjects’ HR stayed within a HR range that corresponds to 60-70% of their VO2Peak HR,
for a duration long enough to achieve a total energy expenditure equivalent to 75% of the
calories of the HFM challenge (Equation 1). However, subjects were not permitted to
exercise longer than 2-hours which included four OA subjects. There was no caloric
replacement after the exercise bout due to the potential impact of partial caloric
replacement on PPL16.
HFM Composition
The HFM which consisted of a slice of Marie Callender's Chocolate Satin Pie
(Conagra Brands, Chicago, IL) portioned out to a caloric density of 12 kcals/kg bw.
Macronutrient composition of the HFM was 57% fat (57% of which is saturated fat), 4%
PRO, and 39% CHO.
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HFM challenge protocol
After reporting to the lab, subjects were seated in a reclining phlebotomy chair and
asked to remain sedentary for the duration of the HFM session, except when inside the
restroom. In the HFM alone condition, subjects were asked to refrain from exercise for at
least 48 hours prior to their visit to the laboratory. After five minutes, two baseline BP
measurements was taken with at least 30 seconds of rest between each recording. An
indwelling safelet catheter was inserted into a forearm vein via a 22-gauge needle (Fisher
Scientific, Waltham, MA) and kept patent with a 0.9% NaCl solution with a drip rate of
one/second. A fasting blood draw was taken once the catheter was in place via a 5 mL
syringe (BD) and emptied into a 6-mL EDTA-coated vacutainer tube.
Blood samples were drawn every 30 minutes postprandially until the two hour mark
at which point draws were performed every hour. Plasma (for inflammatory markers),
blood glucose and lipids (Cardiochek Plus Analyzer, PTS Diagnostics, Indianapolis, IN)
were tested prior to the HFM challenge. Plasma samples were taken at baseline, 3, and 6
hours. Blood glucose was tested every 30 minutes up to 2 hours postprandial, and then
every hour. Blood lipids were tested every hour from baseline until 6 hours post-prandially.
The experimental protocol is pictured in Figure 1.
Cytokine Analysis
After blood draws were transferred to vacutainer tubes, they were immediately
centrifuged for 12 minutes at 1800 x g in 4 degrees Celsius. After being separated blood
plasma was aliquoted into 0.5 ml microtainers and stored for later investigation in a freezer
at -80 C. All plasma samples were assayed at Eve Technologies (Calgary, Alberta,
Canada). A Human High Sensitivity T-Cell Discovery Array 14-plex (HDHSTC14) was
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used to measure IL-6, IL-1β, IL-8, IL-10, and TNF-α. The major pro-inflammatory and
anti-inflammatory cytokine are the primary focus of this paper, while the remaining
cytokines were included as an exploratory aim and part of a larger study. Biomarkers were
analyzed in duplicate and the average measurement was used for analysis.
Statistical Analysis
Statistical analyses were done with IBM SPSS Statistics v26.0 (IBM Corporation,
Armonk, NY). All data were analyzed for normality using the Shapiro-Wilk test.
Considering baseline TG and baseline inflammation markers passed the Shapiro-Wilk test
of normality and appeared to be normally distributed upon inspection of central tendency,
a three-factor analysis of variance was performed with the within-subjects’ factor of time
(baseline, three, and six hours for cytokines; baseline, two, and four hours for glucose;
baseline and every hour postprandially up to 6 hours for lipids) and condition (HFM or
EX+HFM) and the between subjects’ factor of age (YA and OA), and. If significant main
effects of group or time were detected, data were assessed to determine significance as a
linear or quadratic function by contrast analysis. Next, post hoc multiple comparisons were
conducted to test for group- or time-specific differences. In this instance, Bonferroni
adjustment for multiple comparisons were implemented to avoid type I error. Pearson’s r
comparisons were also performed to assess associations between PPL and PPI. For all
analyses, significance was set to p<0.05.
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Results
Participant characteristics
There were no differences in body mass index (BMI) (p=0.454), body fat
percentage (p=0.158), or absolute VO2Peak (p=0.993) between YA and OA. However, there
were significant differences in age (p<0.001), weight (p=0.047) and relative VO2Peak (p
=0.005) between YA and OA. Physical activity level in MET-minutes/week was not
significantly different between age groups (YA=3,776 MET-min/week ± 3,532, OA=6,157
MET-min/week ± 5,456) (p=0.262).
Inflammatory Markers
Figure 3 displays the cytokine response to the HFM for both groups and both
conditions. There was no main effect of time x condition across any of the cytokines
reported at between any timepoints (p >0.05). Figure 3A displays the IL-6 response postHFM. There was a time effect for IL-6 (p <0.001), which decreased from baseline to 3
hours. In examining the change from baseline to 6 hours, the change in IL-6 was significant
as a quadratic function (p<0.001), where IL-6 decreased by 21 ± 23% at 3 hours but by 53
± 95% from 3 to 6 hours back to baseline levels. There was no main effect by age (p=0.774)
and no interaction effects for IL-6 by time x age, time x condition, or time x age x condition
(all p-values>0.05). Figure 3B displays the IL-8 response post-HFM. There was a
significant time effect for IL-8 (p<0.001), which was also significant as a quadratic
function (p<0.001). IL-8 decreased from baseline to 3 hours by 8 ± 20% and increased
from baseline to 6 hours by 2 ± 25% and increased from 3 to 6 hours by 13 ± 23%. There
were no significant effects of time x age (p =0.133), time x condition (p =0.259), or of age
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x condition (p =0.215). There was no main effect of age (p =0.423). Figure 3C displays the
IL-10 response post-HFM. There was a significant effect of time for IL-10 (p<0.001),
which was significant as a quadratic function (p <0.001). IL-10 decreased from baseline to
3 hours by 9 ± 28% and also decreased from baseline to 6 hours 4 ±26%, however increased
from 3 to 6 hours by 7 ±28%. There were no interaction effects of time x condition (p
=0.388), time x age (p =0.357), or in time x condition x age (p =0.641). There was also no
main effect of IL-10 by age (p =0.746). Figure 3D displays the TNF- α response post-HFM.
There was a significant main effect of time (p <0.001), which was also significant as a
quadratic function. TNF- α decreased from baseline to 3 hours by 16.3 ± 19% and baseline
to 6 hours by 10 ± 24%, however increased from 3 to 6 hours by 9 ± 28%. Where was also
no interaction in time x condition x age (p =0.538). However, there was a significant
interaction of time x age (p =0.036), where YA had a greater decrease in TNF- α postHFM, with an attenuated decline from baseline to 6 hours when compared to OA (p =0.04).
OA also had significantly higher TNF- α compared to YA (p =0.047).
Figure 3E displays the IL1-β response post-HFM. There was a significant main
effect of time that decreased linearly from baseline to 6 hours (p <0.001). There were no
interaction effects of time x condition (p =0.485), time x age (p =0.197), or of time x
condition x age (p =0.355). There was also no main effect of age(p =0.553).
Metabolic Data
TG, GLU and LDL are displayed in Figure 4. TG results are displayed from
baseline to 6 hours post-prandially in Figure 4A. There was a significant time effect for TG
(p <0.001), which increased from baseline to 6 hours. There was a trend toward a time x
condition interaction (p =0.06), in the direction of an attenuated increase in TG in the
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EX+HFM condition. There was also a time x age interaction (p =0.035), where the OA had
a greater TG response compared to YA, however there was no interaction time x condition
x age interaction (p =0.714). There was no difference in TG by condition alone between
HFM and EX+HFM (p =0.278) or in age alone between YA and OA (p =0.187).
Figure 4B shows LDL hourly post-HFM. There was a significant time effect for
LDL, where it decreased from baseline to 6 hours post HFM (p =0.001). There was also a
significant time x age interaction (p <0.001), where the OA had an attenuated decline
compared to the YA. There was also a trend for a time x condition x age interaction (p
=0.078), where the OA had greater LDL decline in the EX+HFM condition compared to
the YA EX+HFM condition. LDL was not different between the HFM alone or EX+HFM
condition (p =0.870), however LDL was higher in OA compared to YA (p =0.005).
Post-prandial GLU responses are shown in Figure 4C. There was a significant time
effect for GLU from baseline to 2 hours post-prandially (p<0.001). There was also a
significant time x condition interaction (p =0.002), where EX+HFM lowered post-prandial
glucose compared to the HFM condition alone. There was no time x age or time x condition
x age interaction between time and age (p =0.690 and p =0.728, respectively). There were
no main effects for condition or age (p =0.174 and p =0.457, respectively).
Assosiation Between Metobolic and Inflammatory Markers
Change in TG from baseline to two hours was weakly, negatively associated with
change in IL-3 from baseline to three hours (r=-0.31, p=0.034). There was no association
between TG, GLU, or LDL and any other inflammatory cytokine at any time point either
in absolute value or change score (p>0.05). HDL was weakly, positively associated with
IL-1β at baseline (r=0.345, p=0.018) and at 3 hours postprandially (r=0.378, p=0.008).
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Discussion
The purpose of this study was to determine whether an acute bout of preprandial
exercise would attenuate the PPI response to a HFM in YA and OA. We hypothesized that
(1) an acute bout of physical activity would attenuate the postprandial inflammatory
response in YA and OA and (2) OA would experience a greater attenuation from acute
exercise than YA. Considering that the mechanisms linking PPI and postprandial lipemia
and glycemia remain to be elucidated, an exploratory aim was to assess whether EX had
an impact on TG and GLU, which could subsequently modify PPI. The results do not
support our hypotheses. A HFM did not increase any of the reported inflammatory markers.
Additionally, exercise did not affect the markers of postprandial inflammation that were
analyzed, although there was a main effect of age for TNF-α.
IL-6 is the most frequently reported acute phase cytokine. There was no change in
IL-6 from baseline to six hours. The decrease in IL-6 at three hours was not expected, but
also not unprecedented in the literature. A study by Emerson and colleagues, conducted
within several months as the present study and utilizing the same HFM protocol, observed
a similar quadratic response for IL-611. This IL-6 response was also reported previously in
a study by Teeman and colleagues in which a HFM of 10 kcals/kg BW and 63% fat was
used17. However, there are conflicting reports on the effect of a HFM on postprandial IL6. Postprandial increases in IL-6 have been reported in studies using relative and absolute
caloric meal sizes18–20. Dekker and colleagues measured increased IL-6 over the course of
an 8 hour postprandial period after a 9 kcals/kg BW oral fat tolerance test1. Increases have
also been reported in HFMs with an absolute caloric size as small at 760 kcals with 59%
fat19 to as large as 1,416 kcals with 52% fat20. In addition to HFM composition, subject
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characteristics have also been investigated in their effect on PPI. Changes in postprandial
IL-6 have not been correlated to BMI, age, or HFM caloric load, but have been shown to
have a weak negative correlation with the percent fat of a HFM21. The HFM fat percentage
of the present study falls in between those of studies showing increases in IL-6, thus it is
hard to say whether or not the correlation between HFM fat percentage and IL-6 is
supported. IL-6 does play a role in glucose regulation by promoting hepatic glucagon
secretion22. Perhaps increases in postprandial IL-6 are not influenced by the fat percentage
of a HFM, but rather the carbohydrate content. HFMs that sacrifice carbohydrate content
in exchange for greater fat content may promote increased IL-6 during the postprandial
state to mediate gluconeogenesis rather than inflammatory. All HFM studies are conducted
after a prolonged fast. If the HFM has only low or moderate carbohydrate content,
gluconeogenesis would be likely to occur during an extended postprandial period, as the
subjects have to go for hours without another meal. Another proposed mechanisms for the
differences in postprandial IL-6 across the literature is based on the diurnal changes in IL6. IL-6 has been shown to increase in concentration upon awakening. Because the HFM
sessions in the present study were all performed in the morning, diurnal changes offer an
explanation for the decrease in IL-6 at

3 hours postprandially23,24. If baseline

measurements in the present study were augmented by diurnal changes, a linear increase
in IL-6 might have been observed if baseline measurements were taken further from the
time of subject awakening. However, protocols involving morning HFMs are common
even in experiments that have reported increases in postprandial IL-618–20. Additionally,
baseline IL-6 levels in the present study were not higher than commonly reported in the
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literature19, indicating that the proximity of the HFM to subject awakening likely did not
affect baseline measurements.
TNF-α decreased from baseline to 6 hours. TNF-α is one of the most frequently
measured inflammatory markers in PPI research, however according to a recent review by
Emerson and colleagues, it rarely changes in the postprandial state16. There doesn’t appear
to be a specific HFM fat percentage or caloric load or subject characteristic that consistently
elicits an increase in TNF-α, but there is a connection between TNF- α response and IL-6.
All of the aforementioned studies that elicited increases in IL-6 also reported increases in
TNF-α18–20, while those with no increase in IL-6 measured decreases in both TNF- α and
IL-1β11,17, including the present study. Although the inflammation response has not been
able to be strongly predicted based on meal composition, it appears that the postprandial
response of IL-6 and TNF-α are linked. The specific meal composition and subject
characteristics needed to promote an increase in TNF-α need further investigation.
Downstream pro-inflammatory markers IL-8 and IL-1β decreased from baseline to
6 hours. These markers are reported infrequently but were measured in the present study
in an effort to elucidate more details on PPI cytokine dynamics. Due to the decrease in
TNF-α postprandially, it is not a surprise that the downstream markers followed similar
trends. IL-10 also decreased at both 3 and 6 hours compared to baseline. This postprandial
response of IL-10 was also observed by Teeman and colleagues who speculated that the
decrease in IL-6 might be the reason behind the IL-10 response17. IL-8, IL-1β, and IL-10
may provide more detailed insight into PPI dynamics and the difference in inflammation
between YA and OA. However, in the present study it appears that these downstream
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cytokines simply follow suit with their upstream regulators and may not show any
independent response to a HFM.
Inflammation has been shown to increase during the aging process25. However, the
results from the present study found that TNF-α was the only inflammatory marker to be
affected by age. TNF-α was ~23% higher in OA at baseline compared to YA (p=0.015).
The decline in postprandial TNF-α was also attenuated by age, by which the decrease in
TNF-α postprandially was lesser in OA than YA. Fasting inflammation has been shown
to increase with age with OA having higher levels of IL-6 and TNF-α over time. In
longitudinal work by Bartlett and colleagues, inflammation markers were collected 10
years apart in 249 subjects. After 10 years, TNF-α and IL-6 were 330% and 130% higher,
respectively, demonstrating a large increase in inflammation from the aging process.
However, in the two HFM studies that have investigated YA and OA, no differences in
TNF-α or IL-6 by age has been found11,26. The TNF-α results from the present study do
not agree with the findings from the previous HFM studies by Emerson and colleagues11
and Milan and colleagues26. Emerson and colleagues speculated that the amount of dietary
fiber between groups may have accounted for differences in TNF- α11. Perhaps TNF- α
concentrations in OA is determinant on a combination factors such as diet, physical activity
level, and intensity. More research needs to be done on the effect aging has on
inflammation and the variables that modify age related inflammation.
There was no effect of exercise across time points or age groups for any of the
reported inflammation markers. It is likely that there needs to be PPI in the first place in
order for exercise to elicit any effect. Exercise is anti-inflammatory14. Contracting skeletal
muscle releases IL-6 when glycogen is depleted and mediates an anti-inflammatory
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cascade by increasing IL-10 and actively inhibits TNF-α and IL-1β activity27. Despite our
understanding of the capacity of exercise to reduce inflammation, exercise has not
consistently attenuated PPI in HFM studies17,28,29. Various exercise interventions have been
used across the literature in an attempt to elicit an anti-inflammatory effect on PPI. Previous
exercise interventions have based exercise duration on different set lengths of time28,30 or
on absolute kcal energy expenditures29 , all with similar intensities to the present study.
Unlike previous interventions, the present study used a relative energy expenditure to the
subject’s HFM kcals to see if a greater effect of exercise could be elicited. Although various
durations and energy expenditures have been used in an attempt to attenuate PPI, the main
problem persists that the majority of HFM exercise intervention studies do not use a HFM
that produces any PPI to begin with. As previously discussed, the magnitude of PPI is
inconsistent in the literature with some studies reporting either an absence28 or decline30 in
inflammation and others reporting an increase20. Until a reliable method of inducing PPI is
found, efforts to investigate the effects of exercise on PPI appear to be tedious.
As expected after a HFM, TG and GLU increased in both age groups. OA
experienced higher postprandial TG, but not GLU. These results are similar to previous
research investigating postprandial TG and GLU in YA and regularly active OA in which
active OA experienced greater postprandial TG31. Regular physical activity in OA has
been shown to attenuate postprandial glycemia, but not lipemia compared to inactive OA31.
In a study be Emerson and colleagues, active OA experienced similar postprandial GLU
levels to active YA, but PPL levels were more similar to inactive OA. The OA in the
present study may have had activity levels close to those in Emerson and colleagues’ in
order to attenuate age related change in GLU, but not TG. Exercise attenuated postprandial

34

glycemia at 2 hours in both age groups, but there was only a trend in the effect of exercise
on TG. The proposed mechanism behind PPI is dependent on elevated postprandial LDL
penetrating vascular tissue, however this marker is infrequently reported in HFM studies.
In the present study, LDL decreased postprandially from baseline to six hours in both age
groups. In the study by Dekker and colleagues in which increases in IL-6 and TNF-α were
reported, there was also no change in LDL18. The lack of PPI inducing HFM studies that
also report on postprandial LDL makes it difficult to draw conclusions on whether or not
the proposed mechanism of LDL eliciting PPI is supported. Further muddying the
relationship of LDL to PPI, OA experienced elevated LDL over time compared to YA,
despite not experiencing a consistent increased PPI response compared to YA. The increase
in OA LDL could be a result of the trending increase in TG in OA, however this does not
explain the absence of PPI. There is little support for the association between TG and
PPI28,32. In the present study, TG were not associated with any inflammatory marker.
Furthermore, there was also no association between inflammation and GLU. Evidence
suggests that TG and GLU are not the mediators of a PPI response in the typical HFM
challenge. Further research needs to be done to determine if an alternate metabolic marker
is associated with PPI.
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Conclusion
Our findings question the direct role that HFMs and a western diet play in chronic
inflammatory related diseases. Despite the use of a large HFM that was also high in
saturated fats, no PPI was detected in either age group. The growing body of literature that
has failed to induce PPI after a HFM increases doubt behind the connection of a single
HFM increasing the risk of inflammation related diseases. Investigation into meal timing
and multiple HFM spaced throughout the day may lead to answers on how diet and
behavior work together to promote inflammation and disease. Further research needs to be
done to elucidate the root cause of PPI to be able to consistently produce a PPI state in
experimental trials. Additionally, more work needs to be done to determine whether or not
exercise truly does have a protective effect in PPI and the proper exercise protocols to
generate such effect.
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Table 1. Protocols for incremental VO2peak cycle ergometer test based on subject
determined warm up wattage.
Protocol A

Protocol B

Protocol C

Protocol D

≤ 25

25-50

50-75

≥75

Stage 1
(Watts)

25

25

50

75

Stage 2
(Watts)

35

50

75

100

Additional
Stages

10 W increases

25 W increases

25 W increases

25 W increases

Warm
Wattage

up
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𝑏𝑤𝑘𝑔 ∗ 12.5 𝑘𝑐𝑎𝑙𝑠 ∗ 0.75
𝑎𝑏𝑠𝑜𝑙𝑢𝑡𝑒 𝑉𝑂2 ∗ 4.825𝐿 𝑂2⁄𝑘𝑐𝑎𝑙 ∗ 0.65
Figure 1. Determining exercise duration sufficient to burn 75% of the calories from the
HFM.
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Figure 2. Protocol for the HFM sessions. Time increments are in minutes. P: plasma
collected for inflammation markers, G: glucose collected; L: lipids collected. Satiety
collected via SLIM scale.
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Table 2. Participant characteristics

Age (years)
Height (cm)
Weight (kg)
Body mass index (BMI) (kg/m2)
Body Fat (%)
Absolute VO2peak (L/min)
Relative VO2peak (mL/kg/min)
MET-minutes per week
* Signifies p<0.05 compared to YA.

YA
(7F/5M)
±
23.3
167.5 ±
±
71.4
±
25.3
±
28.2
±
2.3
±
33.4
3,776 ±

3.9
8.1
16.9
5.0
8.7
0.4
5.3
3,532

OA
(4F/8M)
±
67.6
175.9 ±
±
80.7
±
26.7
±
33.1
±
2.3
±
28.3
6,157 ±

6*
8.6
14.7*

P value
<0.000
0.22
0.047

4.3
6.5
0.8
6.7*
5,456

0.454
0.158
0.993
0.005
0.262
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Table 3. High fat meal (HFM) composition and exercise session calculations for YA and OA.
Exercise duration was capped at two hours, there were three OA participants whose calculated
exercise duration exceeded the two hour cap.
YA
OA
(7F/5M)
(4F/8M)
P value
±
±
HFM Calories
856.8
207.1 968.8
180.8 0.172
±
±
HFM Total Fat Calories
488.3
118.1 552.2
103.0 0.172
HFM Saturated Fat Calories
278.4 ± 67
314.8 ± 58.8 0.172
HFM CHO Calories
334.1 ± 80.8
377.8 ± 70.3 0.172
Exercise Energy Expenditure (kcals)
642.6 ± 155.4 726.6 ± 135.6 0.172
Exercise Session Duration (minutes)
88.1 ± 15.1
102.3 ± 18.4 0.053
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a

b

c

Figure 4. Metabolic response to HFM and EX+HFM in YA and OA. (a) triglycerides,
(b) LDL, (c) blood glucose. Dashed lines and empty markers indicated EX+HFM, solid
lines and filled markers indicate HFM, triangles indicate YA and circles indicate Older
adults. * Indicates within group significance compared to baseline. ⱡ Indicates between
group significance for age. # Indicates significance by condition. Error bars indicate
95% CI. Significance set at p<0.05
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a

b

c

d

e

Figure 3. Cytokine response to HFM and EX+HFM in YA and OA at baseline, 3
hours, and 6 hours postprandially. (a) IL-6, (b) IL-8, (c) IL-10, (d) IL-1β, (e) TNFα.
Dashed lines and empty markers indicated EX+HFM, solid lines and filled markers
indicate HFM, triangles indicate YA and circles indicate Older adults. * Indicates
within group significance compared to baseline. ⱡ Indicates between group significance
for age. # Indicates significance by condition. † Indicates significance by age and
condition. Error bars indicate 95% CI. Significance set at p<0.05
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Appendices
Does acute preprandial exercise modify postprandial inflammation after a high fat
meal in young and older adults?
Consent to Participate in Research
Identification of Investigators & Purpose of the Study
You are being asked to participate in a research study conducted by Drs. Stephanie Kurti
and Elizabeth Edwards from James Madison University. To participate, you must be in
good health and able to exercise (per the physical activity readiness-questionnaire and
medical records). The purpose of this study is to determine whether being active impacts
how your body responds to a high-fat meal. Previous research tells us that this response
after a meal is actually a more accurate prediction of your disease risk than fasting levels.
We also want to see if how active you are on a regular basis changes how your body
responds to a high-fat meal. This study will contribute to the knowledge of both
practitioners and clinicians, and may provide an important public health message in
promoting exercise as a way to affect how your body responds to high-fat meals, without
the need for prescription drugs. Should you decide to participate in this research study,
you will be asked to sign this consent form once all your questions have been answered to
your satisfaction.
Research Procedures
This study consists of a series of surveys, a body composition scan, and fitness test that
will be administered to individual participants in the Human Performance Laboratory at
James Madison University. There will be one acute exercise session and two meal sessions.
The total time required for participation in the research study is outlined on the following
page (time required section). The specific procedures during each visit are included here:
Initial visit: If you are older, you will have already have had to receive medical
clearance from your physician to participate in this study prior to your initial visit. On the
first visit to the laboratory, you will be briefed on the study and asked to complete a series
of questionnaires, including the international physical activity questionnaire, the physical
activity readiness-questionnaire plus, and a medical history form. If you’d like to see any
of these questionnaires prior to consenting, please ask a researcher and we’ll be happy to
provide one for you.
On this first day, you’ll also undergo a few tests. First, we’ll assess your height and
weight. Then we’ll perform a DEXA scan to assess your body composition scan (how much
of your body is fat vs. lean mass). Finally, you’ll perform an exercise test on a cycle
ergometer. The exercise test is a test to assess your peak aerobic capacity, which is the best
measure of cardiorespiratory fitness. The exercise bout lasts approximately 12 to 15
minutes until you need to stop or cannot maintain the required cadence. Before and after
the exercise testing, standard pulmonary function tests (PFTs) will be performed, which
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will be repeated at 2 minutes and 20 minutes after the bout of exercise. These tests are
noninvasive and commonly used to assess the capacity of the pulmonary system. An
example of these tests are a breathing maneuver simply requires you to maximally inhale,
then forcefully exhale and hold for 6 seconds, and then to maximally inhale again.
Following the measurements and exercise testing, you will be given an
accelerometer to wear for one week and will return to the laboratory for your second testing
session after the one-week period. Your next visit will either be a meal testing session with
exercise the night before or a meal testing session without exercise the night before.
Meal testing sessions: Your HFM testing sessions will be after a 12 hour
fast. We’ll place an indwelling intravenous catheter inserted into a forearm vein to allow
for repeated blood draws. You will be asked to perform several experimental measurements
prior to consumption of a single high-fat meal (Marie Callender’s Chocolate Satin Pie, 63%
fat, 12 kcal/kg body weight). The meals contain dairy and gluten. These same
measurements will be performed every hour until 6 hours after the HFM. These include
the following: Pulmonary function testing, exhaled nitric oxide, exhaled breath condensate,
blood draws for glucose, triglycerides, and inflammatory and angiogenic markers.
Acute exercise session: On the day that you’re completing the exercise, you’ll
come to the lab 12 hours prior to your meal testing session. At this session, you will
exercise long enough to expend 75% of the calories that will be consumed in the HFM
session. You will exercise on a cycle ergometer at a moderate intensity at 65% of your
VO2peak (which will be based on the cycle test from the first day). Throughout this exercise
session, heart rate data will be monitored continuously.
Blood sample Storage: After collection, your blood will be stored in a deep freezer
on JMU’s campus until all samples have been collected. At that point, the blood will either
be analyzed here at JMU or shipped off to partner labs (e.g. UVA or EVE Technologies)
for analysis there. Any blood shipped to partner sites will be destroyed or returned after
those analyses are complete.
Time Required
Participation in this study will require about 18 hours of your time over the course
of 4 separate visits. Upon completion of the study, you will be compensated $75.00 upon
completion of the study. The visits are outlined below:
Baseline Testing: On the first visit to the laboratory, completing the required forms
and questionnaires, performing the acute exercise test, and undergoing the body
composition scan will take approximately 2 hours.
HFM Visits: Two HFM sessions will each be ~7 hours in length. During this time,
an intravenous catheter will be inserted into the median cubital vein of the forearm and
blood samples will be obtained before the HFM and every hour post-meal for 6
hours. Approximately 10ml of blood will be obtained during each time-point post-HFM.
The catheter will be kept patent by a slow, continuous flow (1 drop/second) of saline
solution. The catheter will remain in the antecubital vein of the participant for the
remainder of the measurement period in order to prevent clotting in the catheter (thus
allowing a single venipuncture for multiple blood samples). The following variables will
be analyzed from these samples: triglycerides, glucose, insulin, angiogenic and
inflammatory markers.
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Acute exercise session: This session will involve an acute bout of exercise that
should last between 30-45 minutes, however may vary from person to person. The exercise
bout will not last longer than 90 minutes in any individual.
Risks
Participation in this study does have some risks, although they are small. The risk
of any serious event during this study is very small. Possible risks include:
Catheter: You may experience discomfort with the placement of the catheter. The
catheter is plastic tubing and allows the arm to be moved throughout the 6-hour testing
session. If excessive discomfort exists, the catheter can be taken out at any time during the
study.
Exercise bout: Both the baseline exercise test and the exercise bout may be
associated with some discomfort and soreness on the following days. This is a normal
physiological response and is not dangerous. During the exercise test, you will have a
mouthpiece in for the duration of the test. This may be uncomfortable and you may
withdraw from the study at any time. Supervision will be provided by research assistants
trained in CPR and AED to minimize any potential risk from the exercise bout. Also, your
heart rate, ventilatory and metabolic data will be continually monitored throughout the
entire exercise bout. If any aberrant responses are recorded, investigators will ask you to
discontinue the exercise.
High-fat meal: The high-fat meal protocol is of very short duration, and any
changes in blood lipids, glucose, or inflammatory markers are unlikely to create any longterm health problems. Additionally, this meal is not out of line with meals consumed on a
regular basis by a significant portion of the US population.
DEXA: The DEXA scan entails a low dose of radiation equivalent to
approximately one transatlantic flight (0.015 mSv= millisievert). While there is no
validated questionnaire to define extensive exposure, increased radiation correlates with
increased risk of cancer and consequently, increased risk of death. However, for reference,
the annual permissible dose for a radiation worker is 5,000 mrem or 5 rem, - which would
be over 3,000 of these scans in one year. The limit for a pregnant worker, the most
conservative level given, is 500mrem - over 300x the dose we are using.
Benefits
By participating in this study, you will learn about your current level of valuable
blood, body composition, and pulmonary values. Your data will be provided to you upon
completion of your participation in the study. If an emergency arises and you must drop
out, you may still receive your data. Having these tests done in a lab would cost several
hundreds of dollars. Additionally, you will be compensated $75 via a JMU Prepaid gift
card for your time during the study.
Society may benefit from more knowledge about how lifestyle affects the
inflammatory, lipemic and angiogenic response to a high-fat meal, which is associated with
cancer and cardiopulmonary disease development. Additionally, society will learn whether
acute exercise is an effective method in older adults to attenuate these deleterious
postprandial responses.
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Confidentiality
The results of this research will be presented at the American College of Sports
Medicine Annual meeting as well as the Experimental Biology annual conference. The
results of this project will be coded in such a way that the respondent’s identity will not be
attached to the final form of this study. The researcher retains the right to use and publish
non-identifiable data. While individual responses are confidential, aggregate data will be
presented representing averages or generalizations about the responses as a whole. All data
will be stored in a secure location accessible only to the JMU researchers. Upon
completion of the study, all information that matches up individual respondents with their
answers will be destroyed.
Participation & Withdrawal
Your participation is entirely voluntary. You are free to choose not to participate.
Should you choose to participate, you can withdraw at any time without consequences of
any kind.
Questions about the Study
If you have questions or concerns during the time of your participation in this study, or
after its completion or you would like to receive a copy of the final aggregate results of this
study, please contact:
Researcher’s Name: Dr. Stephanie Kurti
Email Address: kurtisp@jmu.edu
Cell-Phone number: 630-205-6363

Department of Kinesiology
James Madison University
Office Telephone: 540-568-3947

Researcher’s Name: Dr. Elizabeth Edwards
E-mail Address: edwardes@jmu.edu
Office Telephone: 540-568-5220

Department of Kinesiology
James Madison University

Questions about Your Rights as a Research Subject
Dr. Taimi Castle
Chair, Institutional Review Board
(540) 568-5929
James Madison University
castletl@jmu.edu
Giving of Consent
I have read this consent form and I understand what is being requested of me as a
participant in this study. I freely consent to participate. I have been given satisfactory
answers to my questions. The investigator provided me with a copy of this form. I certify
that I am at least 18 years of age.
______________________________________
Name of Participant (Printed)
______________________________________
Name of Participant (Signed)

______________
Date
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______________________________________
Name of Researcher (Signed)

______________
Date

Attn. Dr. _______

Your patient needs the following physician approval to participate in our JMU research
project.

Physician Approval Form

Patient Name: ___________________________

Project Description:
The purpose of the study is to investigate to determine whether an acute bout of moderateintensity exercise will attenuate the lipemic response to a high-fat meal in active and
inactive older adults. We hypothesize that an acute bout of moderate-intensity exercise will
attenuate the lipemic response to a high-fat meal in active and inactive older adults, with a
greater attenuation of the lipemic response in the inactive older adults.
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When the participant arrives at the laboratory, we will take resting blood pressure and heart
rate, and several pulmonary function tests. These will be performed before and after an
exercise test. The exercise test is performed on a cycle ergometer, where the intensity will
increase every minute by 10-25 watts until volitional exhaustion (it is too hard to turn the
pedals). We monitor heart rate, oxygen saturation, and blood pressure throughout the
exercise test.

Usually the test lasts ~10 minutes, with only 1 or 2 minutes of very hard work, until the
participant wishes to stop the test. All researchers are trained in CPR and our laboratory
has an AED present. We have tested ~50 participants thus far, and nobody has had any
issues during or after the exercise test to fatigue.

We are using American College of Sports Medicine guidelines to determine whether
participants are eligible for participation in the research project. If the individual does not
have a previous heart condition, chest pain when they currently exercise, and is not on any
heart medications, they are able to participate in the test without medical supervision.

However if they have not been exercising recently we ask for physician approval to
participate in the research study. The participant can stop whenever they want during the
test if they feel uncomfortable. Maximal oxygen consumption is the best measure of fitness
level and overall health, and we will discuss the results with them after their session.

Contact: Hannah Frick (frickh1@jmu.edu: (c) 703-638-8892) or Scott Wisseman
(wissemws@dukes.jmu.edu: (c) 703-268-9976) if you have any questions.

Our departmental fax number is: 540-568-3338

I have reviewed the project description and believe the individual is able to complete a
maximal exercise test for the research project.

Printed Name: _________________________________

Signed Name: ___________________________________

Date: ___________
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Additional notes:
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INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE
(October 2002)
LONG LAST 7 DAYS SELF-ADMINISTERED FORMAT

FOR USE WITH YOUNG AND MIDDLE-AGED ADULTS (15-69 years)

The International Physical Activity Questionnaires (IPAQ) comprises a set of 4 questionnaires.
Long (5 activity domains asked independently) and short (4 generic items) versions for use by
either telephone or self-administered methods are available. The purpose of the questionnaires is
to provide common instruments that can be used to obtain internationally comparable data on
health–related physical activity.
Background on IPAQ
The development of an international measure for physical activity commenced in Geneva in 1998
and was followed by extensive reliability and validity testing undertaken across 12 countries (14
sites) during 2000. The final results suggest that these measures have acceptable measurement
properties for use in many settings and in different languages, and are suitable for national
population-based prevalence studies of participation in physical activity.
Using IPAQ
Use of the IPAQ instruments for monitoring and research purposes is encouraged. It is
recommended that no changes be made to the order or wording of the questions as this will affect
the psychometric properties of the instruments.

Translation from English and Cultural Adaptation
Translation from English is encouraged to facilitate worldwide use of IPAQ. Information on the
availability of IPAQ in different languages can be obtained at www.ipaq.ki.se. If a new translation
is undertaken we highly recommend using the prescribed back translation methods available on
the IPAQ website. If possible please consider making your translated version of IPAQ available
to others by contributing it to the IPAQ website. Further details on translation and cultural
adaptation can be downloaded from the website.

Further Developments of IPAQ
International collaboration on IPAQ is on-going and an International Physical Activity
Prevalence Study is in progress. For further information see the IPAQ website.
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More Information
More detailed information on the IPAQ process and the research methods used in the development
of IPAQ instruments is available at www.ipaq.ki.se and Booth, M.L. (2000). Assessment of
Physical Activity: An International Perspective. Research Quarterly for Exercise and Sport, 71 (2):
s114-20. Other scientific publications and presentations on the use of IPAQ are summarized on
the website.
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INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE

We are interested in finding out about the kinds of physical activities that people do as part of their
everyday lives. The questions will ask you about the time you spent being physically active in the
last 7 days. Please answer each question even if you do not consider yourself to be an active
person. Please think about the activities you do at work, as part of your house and yard work, to
get from place to place, and in your spare time for recreation, exercise or sport.

Think about all the vigorous and moderate activities that you did in the last 7 days. Vigorous
physical activities refer to activities that take hard physical effort and make you breathe much
harder than normal. Moderate activities refer to activities that take moderate physical effort and
make you breathe somewhat harder than normal.

PART 1: JOB-RELATED PHYSICAL ACTIVITY
The first section is about your work. This includes paid jobs, farming, volunteer work, course
work, and any other unpaid work that you did outside your home. Do not include unpaid work you
might do around your home, like housework, yard work, general maintenance, and caring for your
family. These are asked in Part 3.

1.

Do you currently have a job or do any unpaid work outside your home?

Yes
No

Skip to PART 2: TRANSPORTATION

The next questions are about all the physical activity you did in the last 7 days as part of your paid
or unpaid work. This does not include traveling to and from work.
2.

During the last 7 days, on how many days did you do vigorous physical activities like
heavy lifting, digging, heavy construction, or climbing up stairs as part of your work?
Think about only those physical activities that you did for at least 10 minutes at a time.

_____ days per week
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No vigorous job-related physical activity
3.

Skip to question 4

How much time did you usually spend on one of those days doing vigorous physical
activities as part of your work?
_____ hours per day
_____ minutes per day

4.

Again, think about only those physical activities that you did for at least 10 minutes at a
time. During the last 7 days, on how many days did you do moderate physical activities
like carrying light loads as part of your work? Please do not include walking.
_____ days per week

No moderate job-related physical activity

5.

Skip to question 6

How much time did you usually spend on one of those days doing moderate physical
activities as part of your work?

_____ hours per day
_____ minutes per day
6.

During the last 7 days, on how many days did you walk for at least 10 minutes at a time
as part of your work? Please do not count any walking you did to travel to or from work.
_____ days per week

No job-related walking

7.

Skip to PART 2: TRANSPORTATION

How much time did you usually spend on one of those days walking as part of your work?
_____ hours per day
_____ minutes per day
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PART 2: TRANSPORTATION PHYSICAL ACTIVITY
These questions are about how you traveled from place to place, including to places like work,
stores, movies, and so on.
8.

During the last 7 days, on how many days did you travel in a motor vehicle like a train,
bus, car, or tram?
_____ days per week

No traveling in a motor vehicle

9.

Skip to question 10

How much time did you usually spend on one of those days traveling in a train, bus, car,
tram, or other kind of motor vehicle?

_____ hours per day
_____ minutes per day
Now think only about the bicycling and walking you might have done to travel to and from work,
to do errands, or to go from place to place.

10.

During the last 7 days, on how many days did you bicycle for at least 10 minutes at a time
to go from place to place?
_____ days per week

No bicycling from place to place

Skip to question 12
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11.

How much time did you usually spend on one of those days to bicycle from place to place?

_____ hours per day
_____ minutes per day
12.

During the last 7 days, on how many days did you walk for at least 10 minutes at a time
to go from place to place?

_____ days per week

No walking from place to place

13.

Skip to PART 3: HOUSEWORK,
HOUSE MAINTENANCE, AND
CARING FOR FAMILY

How much time did you usually spend on one of those days walking from place to place?
_____ hours per day
_____ minutes per day

PART 3: HOUSEWORK, HOUSE MAINTENANCE, AND CARING FOR FAMILY

This section is about some of the physical activities you might have done in the last 7 days in and
around your home, like housework, gardening, yard work, general maintenance work, and caring
for your family.
14.

Think about only those physical activities that you did for at least 10 minutes at a time.
During the last 7 days, on how many days did you do vigorous physical activities like
heavy lifting, chopping wood, shoveling snow, or digging in the garden or yard?
_____ days per week

No vigorous activity in garden or yard

Skip to question 16
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15.

How much time did you usually spend on one of those days doing vigorous physical
activities in the garden or yard?
_____ hours per day
_____ minutes per day

16.

Again, think about only those physical activities that you did for at least 10 minutes at a
time. During the last 7 days, on how many days did you do moderate activities like
carrying light loads, sweeping, washing windows, and raking in the garden or yard?
_____ days per week

No moderate activity in garden or yard
17.

Skip to question 18

How much time did you usually spend on one of those days doing moderate physical
activities in the garden or yard?
_____ hours per day
_____ minutes per day

18.

Once again, think about only those physical activities that you did for at least 10 minutes
at a time. During the last 7 days, on how many days did you do moderate activities like
carrying light loads, washing windows, scrubbing floors and sweeping inside your home?
_____ days per week

No moderate activity inside home

19.

Skip to PART 4: RECREATION,
SPORT AND LEISURE-TIME
PHYSICAL ACTIVITY

How much time did you usually spend on one of those days doing moderate physical
activities inside your home?
_____ hours per day
_____ minutes per day
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PART 4: RECREATION, SPORT, AND LEISURE-TIME PHYSICAL ACTIVITY
This section is about all the physical activities that you did in the last 7 days solely for recreation,
sport, exercise or leisure. Please do not include any activities you have already mentioned.
20.

Not counting any walking you have already mentioned, during the last 7 days, on how
many days did you walk for at least 10 minutes at a time in your leisure time?
_____ days per week

No walking in leisure time
21.

Skip to question 22

How much time did you usually spend on one of those days walking in your leisure time?
_____ hours per day
_____ minutes per day

22.

Think about only those physical activities that you did for at least 10 minutes at a time.
During the last 7 days, on how many days did you do vigorous physical activities like
aerobics, running, fast bicycling, or fast swimming in your leisure time?
_____ days per week

No vigorous activity in leisure time
23.

Skip to question 24

How much time did you usually spend on one of those days doing vigorous physical
activities in your leisure time?
_____ hours per day
_____ minutes per day

24.

Again, think about only those physical activities that you did for at least 10 minutes at a
time. During the last 7 days, on how many days did you do moderate physical activities
like bicycling at a regular pace, swimming at a regular pace, and doubles tennis in your
leisure time?
_____ days per week
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No moderate activity in leisure time

25.

Skip to PART 5: TIME SPENT
SITTING

How much time did you usually spend on one of those days doing moderate physical
activities in your leisure time?
_____ hours per day
_____ minutes per day

PART 5: TIME SPENT SITTING
The last questions are about the time you spend sitting while at work, at home, while doing course
work and during leisure time. This may include time spent sitting at a desk, visiting friends, reading
or sitting or lying down to watch television. Do not include any time spent sitting in a motor vehicle
that you have already told me about.
26.

During the last 7 days, how much time did you usually spend sitting on a weekday?
_____ hours per day
_____ minutes per day

27.

During the last 7 days, how much time did you usually spend sitting on a weekend day?
_____ hours per day
_____ minutes per day

This is the end of the questionnaire, thank you for participating.
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Food Intake Record Directions and Tips
You will have to input all the food that you consume in a day into a nutrition database at
your first and second testing sessions. Also, your food consumption should be the same on both
days before your high-fat meal session.
We will give you a copy of the food that you have consumed so you can remember what to
eat the next time before visiting the laboratory.
Instructions on Use:
•

In the first two columns, note the time and location the food or beverage was consumed.

•

In the third column, record the food or beverage consumed.
o Be as detailed as possible in describing the food item. For example not just chicken, but
how it was prepared (fried, grilled, baked, etc.) and include any sauces or dressings put on
any food item. If you eat a salad, try and write own everything that was in the salad with
appropriate portion sizes.
o Include brand names or restaurant names with the item names whenever possible.
Examples: Kraft, General Mills, Campbell’s’ McDonalds 6 piece McNuggets, etc.
o Include toppings such as mustard, ketchup, mayo, cream sugar, steak sauce, salsa, dressing,
gravy, etc.
o If you are at a restaurant, it is more than OK to ask the staff or waiter/waitress how
something was prepared or about the ingredients in a particular item. Additionally, if you
want, you can include the description off the menu.
o If you have a recipe or a label of a common food you consume, feel free to bring it in. The
more detail you can provide, the better analysis we can provide.

•

Determine serving size for food and beverage (columns 4-6):
o Portion Size: How many?: How many of this item did you consume?
o Portion Size: Food Model: Estimate the size of your food. Options:

•

▪

Use the Food Amounts Booklet as a visual guide.

▪

OR if you’re cooking at home and you know the measured amount, include the
measurements. You can use household measures such as measuring cups and spoons
to further help you estimate how much you consumed.

▪

OR if a weight from the package is available, include the weight.

▪

Notes: Leave this blank unless there is something you would like us to know.

Remember to include all beverages (even water) and snacks consumed.
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•

Be as honest as possible! This really helps with the accuracy of the data that is collected. We
are simply trying to document what you consumed of the recording period.

•

If you have any questions please contact a researcher.

•

Thank you again for your participation. Your accuracy not only assists us with our research,
but provides us a great tool for understanding the impact on your nutrition on several of the
responses to the exercise and acute high-fat feeding sessions.
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ID _________ AC ___________ m0

Using Your Activity Monitor
Thank you for agreeing to wear this Activity Monitor. The Activity Monitor is attached to a black
belt with a clasping buckle that you will put around your waist like a belt. These instructions are
intended to help you get started wearing your Activity Monitor. A phone number is provided at
the end of these instructions should you need to contact us.
Checklist
1. Read all materials in this packet. These instructions contain important information
regarding the proper use of your Activity Monitor.
2. Begin wearing the monitor when you wake up on the Requested Start Date. The
monitor will start working automatically – you DO NOT need to activate it.
3. Wear the monitor during all waking hours for the seven requested days.
4. Stop wearing the monitor at the end of the day on the Requested End Date.
5. For each day you wear the unit, record the exact time of day you put it on, the exact
time you took it off, and any time you did not wear the unit on your Accelerometer
Log.
6. After you have worn the Monitor for seven days, place it back in the padded envelope
and mail it back to us with the completed activity log.

When to Wear the Activity Monitor
•

First, consult the Accelerometer Log form for the actual dates that you should be
wearing your Activity Monitor.

•

The total time you will be wearing the Activity Monitor will be seven days.

•

You should wear it throughout the entire day. We cannot use the data if the monitor
has not been worn during all waking hours. The only times you should NOT wear the
monitor are:
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o While you are sleeping
o When you shower, bathe, or swim (water will damage it)
•

We would like you to wear the monitor for the seven days indicated on the
Accelerometer Log. (See example below.) However, if you are unable to start wearing
the monitor on the requested start date, or you forget to wear it on one of the
requested days, you should continue wearing the monitor until you have worn it for
seven full days.
Day 2
11/29

Day 3
11/30

Day 4
12/1

Day 5
12/3

Day 6
12/4

Day 7
12/5

Time of day you 6:35 am
put on the unit

7:20 am

7:45 am

7:25 am

5:50 am

6:15 am

6:50 am

Time of day you 8:25 pm
took off the unit

9:40 pm

9:25 pm

9:00 pm

8:35 pm

8:15 pm

8:55 pm

Date

Day 1
11/28

Any time you did
12:30
- 6:00-6:50
9:15-9:40
not wear the unit? ------12:50 pm pm
-------------am
(e.g. naps, bathing)
Please provide comments about problems that occurred while you were wearing the unit.
I forgot to wear the monitor on 12/2, so I wore it on 12/5 instead.

How to Wear the Activity Monitor
The Activity Monitor is already attached to a belt that you will wear around your waist.
Following these step-by-step instructions should help you begin wearing your Activity
Monitor:
1. Taking the belt, place it around your waist so that the arrow on the Activity Monitor
is facing away from you and is pointed up towards your head, as in the picture below:

-------
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2. Take both ends of the buckle and connect them so that the belt is attached loosely
around your waist.
3. You may adjust the tightness of the belt by pulling on the straps to make it tighter or
by pulling on the back of the buckle to make it looser. Your belt should be snug, but
not uncomfortably tight. (See “Caring for the Activity Monitor” if you need to make
alterations to your belt.) You may wear the monitor over or under your clothing.
4. The activity monitor should be worn on your left hip. The Activity Monitor should
slide into place along the belt with gentle pressure.

Caring for the Activity Monitor
•

You will probably not need to clean the Activity Monitor. If it gets dirty, however,
simply wiping it with a damp (not wet) rag should be sufficient.

•

If after tightening your belt, there is a lot of excess belt hanging from the buckle, you
may wish to trim it back. To do so, you should:
o Make sure to leave about 3-4 inches excess for adjustment purposes.
o Cut the belt evenly with a pair of scissors.
o Seal the cut end of the belt with some clear nail polish to prevent fraying (if
necessary).

•

You may use a safety pin or rubber band to tie up extra belt rather than cutting it if
you prefer.

Other important notes about your activity monitor:
•

This piece of equipment is very expensive, so please take good care of it!

•

The Activity Monitor is not waterproof, so please avoid getting it wet, as this could
cause damage.
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•

The Activity Monitor may or may not flash. Either way, it is not a cause for any
concern. Trust us – it’s working!

Returning the Activity Monitor
After you have worn the Activity Monitor for a full week, we ask that you return it to us so
that we can collect the data and use it for other participants. When returning the Activity
Monitor to us, you should:
•

Remove the Activity Monitor from your waist.

•

Remember to record your actual end date on the Accelerometer Log and ensure the
rest of the form is complete.

•

Wrap the belt around the Activity Monitor and hold secure with a rubber band.

•

Place the Activity Monitor back in the padded envelope and mail it back to us with
the completed Accelerometer Log.

Activity Monitor Troubleshooting
If you are experiencing problems with your Activity Monitor or have questions, please
contact study coordinator Stephanie Kurti and kurtisp@jmu.edu or 630-205-6363.

Frequently Asked Questions
My activity monitor was blinking and then stopped. Is it still working? Yes, some of the
monitors blink before they start recording activity but some of our newer versions don’t blink at
all. Either way, keep wearing your monitor.
I don’t want the monitor to show when I wear it. Can I wear it underneath my clothes? Yes,
you can wear it over or under your clothes – whatever is most comfortable for you.
My activity monitor seems to ride up and won’t stay on my hip. Some people have said they
have this issue. It will still record but it’s better to have it closer to your hip if possible. You can
try tightening it, pinning the band to your pants, or running the band through your belt loops.
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I accidentally wore the monitor upside down one day. Do I need to wear it for an extra day?
No, as long as you wore the monitor during all of your waking hours you do not need to wear it
for an extra day. The data it collects are still accurate even if it’s upside down.
I forgot to put on my monitor and then went out for the morning. Should I wear it for the
afternoon/evening or just skip today? It is very important that you wear the monitor for the
entire day. If you forget to wear it for part of the day, it is best to skip that day and add an extra
full day to the end instead. Be sure to record this on your log.
My schedule for the week I’m supposed to wear the monitor is not a normal week for me.
Should I still wear it? Yes. The important thing is that you wear it during the time we have
specified. If needed you can make note of any special circumstances on your log.
I am going to be traveling when I’m supposed to wear my monitor. Will I be able to go
through security at the airport? Yes. You will need to take it off just as you do your jewelry.
The x-ray will not harm the device.
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ID _________ AC ___________ m0

Activity Monitor Log
As a participant in this program, we ask that you wear your Activity Monitor for one week. Begin
wearing the monitor on the Requested Start Date. Please try to wear the monitor for seven
consecutive days, but if you do need to skip a day for any reason, continue wearing it until you
have worn it for a full seven days.
Requested Start Date:
Requested End Date:

/

/ 18
/

/ 18

When you get up in the morning
When you go to bed at night

Please record the actual dates/times you wore the accelerometer in the table below. Please be as
precise as possible in reporting the times you put on and removed the monitor.
Day 1

Day 2

Day 3

Day 4

Day 5

Day 6

Date
Time of day you put on
the unit
Time of day you took
off the unit
Any time you did not
wear the unit?
(e.g. naps, bathing)
Please provide comments about problems that occurred while you were wearing the unit.

Day 7
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